NXLIW | Nexalin Technology, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.1024 - 0.1025
52 Week Range	0.1024 - 0.1025
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	1,000
Average Volume	N/A
Shares Outstanding	9,058,950
Market Cap	927,636
Sector	Healthcare
Industry	Medical - Devices
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	6
Country	USA
Website	NXLIW

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.

NXLIW's peers: NEOVW

*Chart delayed

Analyzing fundamentals for NXLIW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see NXLIW Fundamentals page.

Watching at NXLIW technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on NXLIW Technicals page.